Clinical Trial Update: Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nab-paclitaxel in combination with S-1 as induction therapy for locally advanced pancreatic cancer; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Locally Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN